| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30002214 | HIV | ENSG00000125384.8 | protein_coding | PTGER2 | No | No | 5732 | P43116 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PTGER2 |
|---|---|
| DrugBank ID | DB15071 |
| Drug Name | Omidenepag isopropyl |
| Target ID | BE0000368 |
| UniProt ID | P43116 |
| Regulation Type | agonist |
| PubMed IDs | 29332128 |
| Citations | Kirihara T, Taniguchi T, Yamamura K, Iwamura R, Yoneda K, Odani-Kawabata N, Shimazaki A, Matsugi T, Shams N, Zhang JZ: Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent. Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):145-153. doi: 10.1167/iovs.17-22745. |
| Groups | Approved; Investigational |
| Direct Classification | |
| SMILES | CC(C)OC(=O)CNC1=CC=CC(CN(CC2=CC=C(C=C2)N2C=CC=N2)S(=O)(=O)C2=CC=CN=C2)=N1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL4297666 |
